The CEO of NMDP highlights her organization’s work in demonstrating how a rigorous commitment to research that advances clinical practice and patient care can also expand access to cell therapy for all patients.

NIA recipient Parash Prasad, PhD, talks about his research highlighting how metabolic cues from the bone marrow microenvironment can be leveraged to improve transplantation outcomes.

NIA recipient Maria Pereda Ginocchio, MD, details her research dedicated to advancing transplant and cellular therapy science while addressing inequities in access and outcomes for children and families who are often underserved.

NIA recipient Danielle Kirkey, MD, talks about her research goals to change the landscape of immunotherapy in acute myeloid leukemia (AML).

NIA recipient Stosh Ozog, MD, PhD, discusses his goal of characterizing T cell dynamics following hematopoietic cell transplantation.

NIA recipient Sunmin Park, MD, PhD, details the work behind a project focused on developing a novel cellular therapy for GVHD.

NIA recipient Julie Boiko, MD, PhD, talks about her work in tissue macrophage and blood monocyte dynamics of cGVHD.

NIA recipient H. Moses Murdock, MD, discusses working toward safe, tolerable and effective post-transplant maintenance therapies.

Luke Maillie, MD, discusses the work and science behind his award-winning project on post-treatment long-term neurologic symptoms.